Collegium Pharmaceutical Inc — Quarterly Financial Statistics (NASDAQ:COLL) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Cash from operating activities -9 M84.64 M55.4 M72.44 M78.44 M123.05 M 329.32 M Cash from investing activities 248.96 M11.76 M9.68 M2.92 M30.87 M20.07 M 63.53 M Cash from financing activities -149.03 M41.28 M25.24 M48.37 M14.82 M21.82 M 110.25 M Free cash flow -9.24 M84.07 M54.6 M72.37 M78.25 M122.36 M 327.58 M

Haberler

Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates

Collegium’un 4Ç 2025 sonuçları: DEHB ilacı yükseldi ancak kazanç beklentileri tutmadı

Collegium Q4 2025 slides: ADHD drug surges despite earnings miss

Collegium Pharmaceutical kazancı $0,10 ile beklentilere göre daha kötü, kâr ise beklentilere göre düşük

Collegium Pharmaceutical earnings missed by $0.10, revenue fell short of estimates

Collegium Pharmaceutical kazanç raporu: Jornay PM odakta

Collegium Pharmaceutical earnings ahead: Jornay PM in focus

Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow: Should You Buy?

Collegium Pharmaceutical to Report Q4 Earnings: What's in the Cards?

Madrigal (MDGL) Reports Q4 Loss, Beats Revenue Estimates

Truist Securities raises Collegium Pharmaceutical stock price target to $58

Collegium Pharmaceutical Stock: Buying The Projected Growth For 2026 (NASDAQ:COLL)